Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenerimod dose-ranging placebo-controlled phase 2 trial in active systemic lupus erythematosus
MOH_2019-04-17_007090Phase 2Active, not recruiting
- Sponsor
- Idorsia
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cenerimod in systemic lupus erythematosus (SLE) (5 arms), sponsored by Idorsia. Started Mar 2019; status: active, not recruiting.
02
Drugs
cenerimod
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on MOH_2019-04-17_007090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-04-17_007090.